Key result
HeartMate 3 LVAD supports normal physical activity at 12 months in a pediatric case.
Why the study?
Heart assist devices can be used as a bridge to transplantation in children with dilated cardiomyopathy and drug-resistant heart failure after viral myocarditis.
Does left ventricular assist device implantation improve clinical status in a child with small body surface area and dilated cardiomyopathy?
Case Report (n=1)
Does left ventricular assist device implantation improve clinical status in a child with small body surface area and dilated cardiomyopathy?
Implantation of a left ventricular assist device is feasible and can improve clinical status in children with a small body surface area.
No takes yet. Share an insight, caveat, or question.
Supports feasibility in select small children; hypothesis-generating and requires prospective validation before wider use.
Soynov et al. (2024) conducted a case report in Dilated cardiomyopathy after viral myocarditis (n=1). Heart Mate 3 left ventricular assist device was evaluated on Clinical status and physical activity. Implantation of a Heart Mate 3 left ventricular assist device in an 11-year-old girl with a small body surface area resulted in asymptomatic clinical status and normal physical activity at 12 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: